2020
Neighborhood Deprivation and Adherence to Initial Diabetic Retinopathy Screening
Yusuf R, Chen EM, Nwanyanwu K, Richards B. Neighborhood Deprivation and Adherence to Initial Diabetic Retinopathy Screening. Ophthalmology Retina 2020, 4: 550-552. PMID: 32139294, PMCID: PMC8281953, DOI: 10.1016/j.oret.2020.01.016.Peer-Reviewed Original Research
2019
Barriers to and Facilitators of Diabetic Retinopathy Screening Utilization in a High-Risk Population
Fairless E, Nwanyanwu K. Barriers to and Facilitators of Diabetic Retinopathy Screening Utilization in a High-Risk Population. Journal Of Racial And Ethnic Health Disparities 2019, 6: 1244-1249. PMID: 31463812, PMCID: PMC6880869, DOI: 10.1007/s40615-019-00627-3.Peer-Reviewed Original ResearchConceptsHigh-risk populationEye examDiabetic retinopathyVision lossQualified community health centersCommunity health centersLow socioeconomic statusUse of screeningBackgroundDiabetic retinopathyMedian ageEye careHealth centersClinic experienceDiabetesPatientsVision statusRetinopathyConclusionsThe factorsMethodsQualitative interviewsVisual symptomsSocioeconomic statusHealth insuranceImportant facilitatorsExamParticipants
2013
Predicting Development of Proliferative Diabetic Retinopathy
Nwanyanwu K, Talwar N, Gardner TW, Wrobel JS, Herman WH, Stein JD. Predicting Development of Proliferative Diabetic Retinopathy. Diabetes Care 2013, 36: 1562-1568. PMID: 23275374, PMCID: PMC3661803, DOI: 10.2337/dc12-0790.Peer-Reviewed Original ResearchMeSH KeywordsAgedDiabetic RetinopathyFemaleHumansMaleMiddle AgedMultivariate AnalysisRetrospective StudiesConceptsNonproliferative diabetic retinopathyDiabetic retinopathy progressionRetinopathy progressionDiabetic retinopathyMultivariable Cox regression analysisProgression risk scoreHigh-risk patientsRetrospective cohort analysisCox regression analysisProliferative diabetic retinopathyFive-year probabilityLow-risk individualsCare recipient ageAdvanced diseaseRecipient ageDiabetes mellitusGlycemic controlClaims databaseVision lossDisease progressionCohort analysisRisk scoreManaged-care networkPredicting DevelopmentRetinopathyCost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema
Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW. Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema. Ophthalmology 2013, 120: 1835-1842. PMID: 23642372, PMCID: PMC3737388, DOI: 10.1016/j.ophtha.2013.02.002.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabCombined Modality TherapyCost-Benefit AnalysisDiabetic RetinopathyDiagnostic Techniques, OphthalmologicalDrug CostsFinancing, PersonalGlucocorticoidsHealth Care CostsHumansIntravitreal InjectionsLaser CoagulationMacular EdemaMarkov ChainsMiddle AgedQuality-Adjusted Life YearsRanibizumabTriamcinolone AcetonideVascular Endothelial Growth Factor AConceptsQuality-adjusted life yearsProbabilistic sensitivity analysesTime horizonSensitivity analysisCost-effectiveness analysisWTP valuesCost-effective treatment optionLife yearsIncremental costMedicare fee scheduleWTPHypothetical cohortFee scheduleCSDMECostHorizonFinancialMarkov modelWillingnessOptions